Clearmind Other Current Assets vs Cash And Short Term Investments Analysis
| CMND Stock | USD 1.33 0.01 0.75% |
Clearmind Medicine financial indicator trend analysis is way more than just evaluating Clearmind Medicine Common prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clearmind Medicine Common is a good investment. Please check the relationship between Clearmind Medicine Other Current Assets and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Other Current Assets vs Cash And Short Term Investments
Other Current Assets vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clearmind Medicine Common Other Current Assets account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Clearmind Medicine's Other Current Assets and Cash And Short Term Investments is 0.68. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Clearmind Medicine Common, assuming nothing else is changed. The correlation between historical values of Clearmind Medicine's Other Current Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Clearmind Medicine Common are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Current Assets i.e., Clearmind Medicine's Other Current Assets and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.68 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Clearmind Medicine Common balance sheet. This account contains Clearmind Medicine investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Clearmind Medicine Common fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Clearmind Medicine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clearmind Medicine Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Clearmind Medicine's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 414.2 K, whereas Enterprise Value Over EBITDA is forecasted to decline to 0.40.
Clearmind Medicine fundamental ratios Correlations
Click cells to compare fundamentals
Clearmind Medicine Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Clearmind Medicine fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 512.7K | 5.2M | 1.1M | 4.3M | 5.0M | 5.2M | |
| Total Current Liabilities | 13.4K | 357.2K | 2.6M | 3.6M | 4.2M | 4.4M | |
| Total Stockholder Equity | 499.3K | 4.8M | (1.5M) | 1.4M | 1.6M | 1.6M | |
| Net Tangible Assets | 133.8K | 319.6K | 4.6M | (1.7M) | (1.9M) | (1.8M) | |
| Retained Earnings | (539.7K) | (4.4M) | (13.8M) | (13.6M) | (12.3M) | (11.7M) | |
| Accounts Payable | 4.0K | 281.5K | 1.0M | 448.2K | 515.4K | 541.2K | |
| Cash | 329.8K | 4.6M | 175.8K | 3.9M | 4.5M | 4.7M | |
| Total Liab | 13.4K | 357.2K | 2.6M | 3.6M | 4.2M | 4.4M | |
| Total Current Assets | 333.0K | 4.9M | 593.3K | 4.2M | 4.8M | 5.1M | |
| Common Stock | 891.7K | 7.9M | 9.2M | 12.4M | 14.3M | 15.0M | |
| Other Current Liab | 6.1K | 6.7K | 1.6M | 3.2M | 3.6M | 3.8M | |
| Property Plant And Equipment Net | 179.7K | 20.6K | 66.4K | 1.2K | 1.1K | 1.1K | |
| Net Debt | (329.8K) | (4.6M) | (123.4K) | (3.9M) | (3.5M) | (3.4M) | |
| Non Current Assets Total | 179.7K | 238.6K | 534.7K | 115.3K | 132.6K | 224.1K | |
| Cash And Short Term Investments | 329.8K | 4.6M | 440.2K | 4.0M | 4.6M | 4.8M | |
| Net Receivables | 3.1K | 129.8K | 133.7K | 174.6K | 200.8K | 210.8K | |
| Liabilities And Stockholders Equity | 512.7K | 5.2M | 1.1M | 4.3M | 5.0M | 5.2M | |
| Non Current Liabilities Total | 7.6K | 12.7K | 5.3K | 348.9K | 2.0M | 0.0 | |
| Common Stock Shares Outstanding | 18.1K | 30.9K | 43.3K | 202.5K | 232.9K | 244.5K | |
| Other Stockholder Equity | 369.7K | 2.9M | 2.5M | 2.6M | 3.0M | 1.6M | |
| Net Invested Capital | 499.3K | 4.8M | (1.5M) | 983.5K | 885.1K | 785.4K | |
| Capital Stock | 891.7K | 7.9M | 9.2M | 17.1M | 19.7M | 20.7M | |
| Net Working Capital | 319.6K | 4.6M | (2.0M) | 824.8K | 742.3K | 579.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Return On Assets (0.58) | Return On Equity (2.68) |
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.